Theraflu Cold And Flu Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Intensifies the effect of MAO inhibitors, sedative preparations, ethanol. The risk of the hepatotoxic action of paracetamol increases during concurrent use of barbiturates, diphenine, carbamazepine, rifampicin, zidovudine, and other hepatic microsomal enzyme inducers. Antidepressants, antiparkinsonian agents, antipsychotic agents, and phenothiazine derivatives - increase the risk of developing urinary retention, dry mouth, and constipation. Glucocorticosteroids increase the risk of developing elevated intraocular pressure.
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Infectious/inflammatory illnesses - influenza, ARVI (“common cold”), accompanied by a high temperature, chills, and fever, headache, rhinitis and nasal congestion, sneezing, and muscle pain
There is currently no drug history available for this drug.
Loose white powder containing white, yellow, and gray-violet granules. May contain soft clumps.
When one packet is dissolved in hot water, a cloudy solution forms which is pink-violet in color with a berry aroma.